Ping An Biomedical Co., Ltd. (PASW) - Total Liabilities
Based on the latest financial reports, Ping An Biomedical Co., Ltd. (PASW) has total liabilities worth $23.17 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ping An Biomedical Co., Ltd. - Total Liabilities Trend (2021–2025)
This chart illustrates how Ping An Biomedical Co., Ltd.'s total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Ping An Biomedical Co., Ltd. to evaluate short-term liquidity relative to the company's equity base.
Ping An Biomedical Co., Ltd. Competitors by Total Liabilities
The table below lists competitors of Ping An Biomedical Co., Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Green Critical Minerals Ltd
AU:GCM
|
Australia | AU$592.06K |
|
Coats Group PLC
LSE:COA
|
UK | GBX1.24 Billion |
|
Shenzhen Wongtee International Enterprise Co Ltd
SHE:200056
|
China | HK$7.81 Billion |
|
Kodi-S Co Ltd
KQ:080530
|
Korea | ₩24.56 Billion |
|
Scanwolf Corporation Bhd
KLSE:7239
|
Malaysia | RM105.77 Million |
|
FAR Ltd
AU:FAR
|
Australia | AU$6.08 Million |
|
IXUP Ltd
AU:IXU
|
Australia | AU$2.67 Million |
|
Invoicery Group AB
ST:FRILAN
|
Sweden | Skr269.63 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Ping An Biomedical Co., Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Ping An Biomedical Co., Ltd. worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.76 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.51 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ping An Biomedical Co., Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ping An Biomedical Co., Ltd. (2021–2025)
The table below shows the annual total liabilities of Ping An Biomedical Co., Ltd. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-09-30 | $23.17 Million | -63.81% |
| 2024-09-30 | $64.04 Million | -25.28% |
| 2023-09-30 | $85.70 Million | +10.80% |
| 2022-09-30 | $77.35 Million | +2.08% |
| 2021-09-30 | $75.77 Million | -- |
About Ping An Biomedical Co., Ltd.
Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. It also engages in the manufacturing and trading of yarns, textiles, and finish… Read more